EFFICACY AND SAFETY OF HISTRELIN SUBDERMAL IMPLANT IN PATIENTS WITH ADVANCED PROSTATE CANCER

The results of Histrelin Study Group investigation of efficacy and safety of Vantas «Orion» (subdermal implant of 50 mg of histrelin acetate) in men with advanced prostate cancer (III–IV st.) are analized.